Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 2 | $44,476 |
Sells | 18 | $62,779,686 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
05 Mar 2024 16:00 | BBIO | BridgeBio Pharma Inc | SCOTT RANDAL W. | Director | 01 Mar 2024 | Sale | 2,500 | 34 | 85,000 | I |
20 Feb 2024 16:03 | BBIO | BridgeBio Pharma Inc | VALANTINE HANNAH | Director | 15 Feb 2024 | Sale | 2,915 | 37.75 | 110,041 | D |
13 Feb 2024 16:00 | BBIO | BridgeBio Pharma Inc | VALANTINE HANNAH | Director | 28 Dec 2021 | Purchase | 1,891 | 13.18 | 24,923 | I |
13 Feb 2024 16:00 | BBIO | BridgeBio Pharma Inc | VALANTINE HANNAH | Director | 28 Dec 2021 | Purchase | 1,542 | 12.68 | 19,553 | I |
18 Jan 2024 16:10 | BBIO | BridgeBio Pharma Inc | VALANTINE HANNAH | Director | 16 Jan 2024 | Sale | 2,915 | 37.97 | 110,683 | D |
28 Dec 2023 16:00 | BBIO | BridgeBio Pharma Inc | MCCORMICK FRANK | Director | 26 Dec 2023 | Sale | 100,000 | 42.06 | 4,206,000 | I |
20 Dec 2023 16:00 | BBIO | BridgeBio Pharma Inc | SCOTT RANDAL W. | Director | 18 Dec 2023 | Sale | 2,000 | 40 | 80,000 | I |
19 Dec 2023 16:00 | BBIO | BridgeBio Pharma Inc | VALANTINE HANNAH | Director | 15 Dec 2023 | Sale | 2,915 | 36.12 | 105,290 | D |
05 Dec 2023 16:00 | BBIO | BridgeBio Pharma Inc | SCOTT RANDAL W. | Director | 01 Dec 2023 | Sale | 1,500 | 30 | 45,000 | I |
05 Dec 2023 16:00 | BBIO | BridgeBio Pharma Inc | SCOTT RANDAL W. | Director | 01 Dec 2023 | Sale | 1,000 | 28.5 | 28,500 | I |
20 Nov 2023 16:00 | BBIO | BridgeBio Pharma Inc | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 17 Nov 2023 | Sale | 22,685 | 29.0967 | 660,059 | D |
20 Nov 2023 16:00 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | CEO and President | 17 Nov 2023 | Sale | 200 | 29.55 | 5,910 | D |
20 Nov 2023 16:00 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | CEO and President | 17 Nov 2023 | Sale | 51,352 | 29.0958 | 1,494,128 | D |
17 Nov 2023 16:09 | BBIO | BridgeBio Pharma Inc | VALANTINE HANNAH | Director | 15 Nov 2023 | Sale | 2,915 | 30 | 87,450 | D |
07 Sep 2023 16:00 | BBIO | BridgeBio Pharma Inc | SCOTT RANDAL W. | Director | 05 Sep 2023 | Sale | 2,500 | 30 | 75,000 | I |
18 Aug 2023 16:00 | BBIO | BridgeBio Pharma Inc | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 17 Aug 2023 | Sale | 22,683 | 28.5877 | 648,455 | D |
18 Aug 2023 16:00 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | CEO and President | 17 Aug 2023 | Sale | 51,552 | 28.5883 | 1,473,784 | D |
19 Jul 2023 21:33 | BBIO | BridgeBio Pharma Inc | VIKING GLOBAL INVESTORS LP | 10% | 18 Jul 2023 | Sale | 1,500,000 | 35 | 52,500,000 | I |
18 May 2023 16:07 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | CEO and President | 17 May 2023 | Sale | 51,552 | 14.0095 | 722,218 | D |
18 May 2023 16:02 | BBIO | BridgeBio Pharma Inc | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 17 May 2023 | Sale | 24,424 | 14.0095 | 342,168 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)